A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID’s neurological symptoms.
1 Ernst Str ü ngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, Frankfurt, Germany 2 Brain Research Institute, Universit ä t Bremen,…
Background and ObjectivesRace and ethnicity are proxy measures of sociocultural factors that influence cognitive test performance. Our objective was to compare different regression-based cognitive normative…
Neurology Today reports on breaking news, issues, and trends in the practice and science of neurolog
A new study reveals that individuals with chronic traumatic encephalopathy (CTE) and a family history of mental illness have a heightened risk of aggression during…
A new study demonstrates that large language models (LLMs) can predict the outcomes of neuroscience studies more accurately than human experts, achieving 81% accuracy compared…
Background and ObjectivesExposure to repetitive head impacts (RHI) is linked to the development of chronic traumatic encephalopathy (CTE), which can only be diagnosed at post-mortem.…
Click on the article title to read more.
Dihydroergotamine (DHE) is an effective migraine treatment that has been available for over 70 years. However, the relationship between the amount of DHE in the blood,…
Background and ObjectivesAlthough most spontaneous intracerebral hemorrhages (ICHs) are due to cerebral small vessel diseases (SVDs), between 1 in 7 and 1 in 10 are…
The fact that rapid brain size increase was clearly a key aspect of human evolution has prompted many studies focusing on this phenomenon, and many…
